# Hugh Auchincloss

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hugh-auchincloss/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,076 |
| Field | T-cell and B-cell Immunology |
| h-index | 54 |
| i10-index | 128 |
| Last Known Institution | Massachusetts General Hospital |
| OpenAlex ID | https://openalex.org/A5024609857 |
| Works | 278 |

## Researcher papers

- [International Trial of the Edmonton Protocol for Islet Transplantation](https://scholariq.org/papers/international-trial-of-the-edmonton-protocol-for-islet-transplantation/)
- [The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice](https://scholariq.org/papers/the-programmed-death-1-pd-1-pathway-regulates-autoimmune-diabetes-in-nonobese/)
- [XENOGENEIC TRANSPLANTATION](https://scholariq.org/papers/xenogeneic-transplantation/)
- [XENOGENEIC TRANSPLANTATION](https://scholariq.org/papers/xenogeneic-transplantation-2/)
- [Direct and indirect recognition: the role of MHC antigens in graft rejection](https://scholariq.org/papers/direct-and-indirect-recognition-the-role-of-mhc-antigens-in-graft-rejection/)
- [The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice.](https://scholariq.org/papers/the-role-of-indirect-recognition-in-initiating-rejection-of-skin-grafts-from/)
- [A PHASE I TRIAL OF IMMUNOSUPPRESSION WITH ANTIIC AM-1 (CD54) mAb IN RENAL ALLOGRAFT RECIPIENTS](https://scholariq.org/papers/a-phase-i-trial-of-immunosuppression-with-antiic-am-1-cd54-mab-in-renal/)
- [Mice lacking major histocompatibility complex class I and class II molecules.](https://scholariq.org/papers/mice-lacking-major-histocompatibility-complex-class-i-and-class-ii-molecules/)
- [A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients1](https://scholariq.org/papers/a-prospective-randomized-clinical-trial-of-intraoperative-versus-postoperative/)
- [SYMPTOMATIC CYTOMEGALOVIRUS DISEASE IN THE CYTOMEGALOVIRUS ANTIBODY SEROPOSITIVE RENAL TRANSPLANT RECIPIENT TREATED WITH OKT31,2](https://scholariq.org/papers/symptomatic-cytomegalovirus-disease-in-the-cytomegalovirus-antibody-seropositive/)
- [Objective performance indicators provide a novel, quantitative method to evaluate surgeon proficiency in robotic lobectomy training](https://scholariq.org/papers/objective-performance-indicators-provide-a-novel-quantitative-method-to-evaluate/)

## Researcher topics

- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Xenotransplantation and immune response](https://scholariq.org/topics/xenotransplantation-and-immune-response/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

## Researcher university

- [Massachusetts General Hospital](https://scholariq.org/institutions/massachusetts-general-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.